NCT06253052已完成不适用
A Pilot Study to Test Benefits of Drinking Clear Fluids Until Called to the Operating Room in Adult Surgical Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 174
- 试验地点
- 2
- 主要终点
- Thirst
研究概览
简要总结
The purpose of this study is to show if - compared to standard practice - allowing adults undergoing surgical procedures under anaesthesia care to drink clear fluids up to a volume of 200 ml between 2 h prior to the operation and the call to operation room (approximately 30 min prior to anaesthesia induction) will decrease patient thirst and increase patient satisfaction.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Adult patients (≥ 18 years)
- •American Society of Anesthesiologists (ASA) physical status classification I-III
- •Undergoing surgical procedure under anaesthesia care: general anaesthesia, regional anaesthesia, combined anaesthesia or monitored anaesthesia care.
- •The proportion of Patients undergoing general or combined anaesthesia is aimed to exceed 75%
排除标准
- •Absolute indication for rapid sequence induction including but not limited to:
- •Bowel obstruction including ileus
- •Stricture and oesophageal disorders including achalasia
- •Recent polytrauma or trauma of the upper gastrointestinal tract
- •Acute abdomen/peritonitis including active gastrointestinal bleeding
- •Relative indication for (modified) rapid sequence induction includes, but is not limited to:
- •Symptomatic gastroesophageal reflux disease, independent of food intake and persistent under medical treatment (PPI)
- •Hiatus hernia or upside down stomach
- •Upper gastrointestinal tumour
- •History of upper gastrointestinal surgery (oesophageal, gastric, duodenum, pancreatic)
- •Medically confirmed gastroparesis
- •Severe obesity, defined as body mass index ≥ 40 kg/m2
- •Renal replacement therapy
- •Fluid restriction therapy
- •Expected need for postoperative mechanical ventilation
结局指标
主要结局
Thirst
时间窗: Prior to induction of anaesthesia
At any stage after your hospital admission have you had the following: Thirst (No/ Yes, moderate/ Yes, severe)
次要结局
- Total number of protocol deviations per group(From enrollment until last Follow-up is concluded at up to 48 hours post surgery)
- Fluid fasting time(Prior to induction of anesthesia)
- RASS(2 hours after end of surgery)
- CAM-ICU(2 hours after end of surgery)
- Headache(Prior to induction of anesthesia and 2 hours after end of surgery)
- Change of diastolic blood pressure on induction of anesthesia(5 minutes prior and 15 minutes after induction of anesthesia)
- Change of mean arterial pressure on induction of anesthesia(5 minutes prior and 15 minutes after induction of anesthesia)
- Vasopressor(Within 15 minutes after induction of anesthesia)
- Blood glucose level(At induction of anesthesia (Values assessed within 15 minutes prior and 15 minutes after induction of anesthesia will be accepted))
- Intravenous catheter placement(Between admission to the operation room and induction of anesthesia)
- Postoperative nausea and vomiting(2 hours after end of surgery)
- Unplanned ICU/IMC(From end of surgery until last Follow-up is concluded at up to 48 hours post surgery)
- Change of heart rate on induction of anesthesia(5 minutes prior and 15 minutes after induction of anesthesia)
- Change of systolic blood pressure on induction of anesthesia(5 minutes prior and 15 minutes after induction of anesthesia)
- Number of Participants with confirmed bronchopulmonary aspiration(From induction of anesthesia until last Follow-up is concluded at up to 48 hours post surgery)
- All cause mortality(From end of surgery until last Follow-up is concluded at up to 48 hours post surgery)
- Patient satisfaction(2 hours after end of surgery)
研究者
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
不适用
Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD).Steatohepatitis, NonalcoholicSteatosisLiver DiseasesSteatohepatitisNCT05946330Universidade Federal do Paraná10
已完成
1 期
An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral IllnessRespiratory Viral InfectionAntiviral TreatmentCOVID-19NCT05381454University of California, Los Angeles80
已完成
1 期
PARTNER Recruitment and Brief Intervention Pilot StudyAlcohol AbuseNCT00735956Duke University300
已完成
3 期
Women's Health Habits StudyRisk Drinking,Diabetes, Hypertension, Osteoporosis, InfertilityNCT00846638Brigham and Women's Hospital611
进行中（未招募）
不适用
Brief Intervention and Fibroscan for Harmful Drinkers Presenting to the Emergency DepartmentAlcohol Use Disorder (AUD)NCT05720247Nottingham University Hospitals NHS Trust80